Actively Recruiting
Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
Led by RenJi Hospital · Updated on 2024-12-10
80
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been proved to enable tumor excision with relatively better renal function preservation comparing with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a randomized clinical trial in single center. The investigators want to explore this technique to robotic surgery and add suture-less technique to T1 RCC patients in randomized clinical trial.
CONDITIONS
Official Title
Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with sporadic, unilateral, newly diagnosed T1 presumed renal cell carcinoma
- Patients scheduled for robot-assisted laparoscopic nephron sparing surgery
- Patients with normal contralateral renal function (differential renal function of >40% as determined by radionuclide scintigraphy)
- Patients agreeable to participate in this long-term follow-up study
You will not qualify if you...
- Patients older than 80 years
- Patients with other kidney diseases that may affect renal function of the operated kidney (including kidney stones, glomerular nephritis, etc.)
- Patients unable to tolerate robot-assisted laparoscopic surgery
- Patients with previous kidney surgery or any inflammatory conditions of the operated kidney
- Patients with renal tumors involving the urinary collecting system or with tumor edge within 4 mm of the collecting system
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ethics Committee of Shanghai Renji Hospital
Shanghai, China
Actively Recruiting
Research Team
J
Jiwei Huang, PhD.
CONTACT
Y
Yiran Huang, MD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here